Literature DB >> 8314608

Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.

G M Anderson1, K J Kerluke, I R Pulcins, C Hertzman, M L Barer.   

Abstract

This paper uses claims data from the prescription drug program for the elderly in British Columbia to describe temporal trends in prescription drug use and the determinants of those trends. Drug expenditures under the program increased by 317% from $21.6 million in 1981-82 to $90 million in 1988-89. Of the $68.4 million-dollar increase in overall expenditures, 34% was due to new drugs, 24% to increased age-specific utilization rates of old drugs, 21% to increased prices of old drugs, and 14% to the increased size of the elderly population. The analysis indicates that 61.5% of new drug expenditures can be attributed to four specific drugs and that the relative importance of price and utilization rates in determining changes in expenditures on old drugs varies by drug category. The paper provides a framework for understanding and predicting expenditures for drug benefit plans.

Entities:  

Mesh:

Year:  1993        PMID: 8314608

Source DB:  PubMed          Journal:  Inquiry        ISSN: 0046-9580            Impact factor:   1.730


  16 in total

1.  Statistics and drug utilization: are prescribing rates really that high?

Authors:  S Morgan
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

Review 2.  Revisiting the O complex: urinary incontinence, delirium and polypharmacy in elderly patients.

Authors:  D B Hogan
Journal:  CMAJ       Date:  1997-10-15       Impact factor: 8.262

3.  Prescription drug coverage: an essential service or a fringe benefit?

Authors:  Robyn M Tamblyn
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

4.  Time series evaluation of an intervention to increase statin tablet splitting by general practitioners.

Authors:  Jennifer M Polinski; Sebastian Schneeweiss; Malcolm Maclure; Blair Marshall; Samuel Ramsden; Colin Dormuth
Journal:  Clin Ther       Date:  2011-02       Impact factor: 3.393

5.  A cross-national study of the persistence of antihypertensive medication use in the elderly.

Authors:  Boris L G van Wijk; William H Shrank; Olaf H Klungel; Sebastian Schneeweiss; M Alan Brookhart; Jerry Avorn
Journal:  J Hypertens       Date:  2008-01       Impact factor: 4.844

6.  Driving forces behind increasing cardiovascular drug utilization: a dynamic pharmacoepidemiological model.

Authors:  Helle Wallach Kildemoes; Henrik Støvring; Morten Andersen
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

7.  Drug expenditure trends in the Canadian provinces: magnitude and causes from 1998 to 2004.

Authors:  Steve Morgan
Journal:  Healthc Policy       Date:  2005-09

8.  Reflections on a month in the life of the Ontario Drug Benefit Plan.

Authors:  W McIsaac; C D Naylor; G M Anderson; B J O'Brien
Journal:  CMAJ       Date:  1994-02-15       Impact factor: 8.262

9.  Hospital downsizing and trends in health care use among elderly people in British Columbia.

Authors:  S B Sheps; R J Reid; M L Barer; H Krueger; K M McGrail; B Green; R G Evans; C Hertzman
Journal:  CMAJ       Date:  2000-08-22       Impact factor: 8.262

Review 10.  Cost of pharmacological care of the elderly: implications for healthcare resources.

Authors:  Ciaran O'Neill; Carmel M Hughes; James Jamison; Anna Schweizer
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.